MATTHEW HENDRICKS: Open Payments
NPI 1033684873 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,166 in 175 payments from 22 companies in 2025. Trend: 2023 $2,452 · 2024 $3,290 · 2025 $3,166
Food & beverage: $3,078Education: $88
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $506 |
| Regeneron Healthcare Solutions, Inc. | 12 | $410 |
| Galderma Laboratories, L.P. | 19 | $335 |
| Janssen Biotech, Inc. | 15 | $313 |
| Arcutis Biotherapeutics, Inc. | 32 | $299 |
| UCB, Inc. | 6 | $201 |
| GENZYME CORPORATION | 6 | $177 |
| Novartis Pharmaceuticals Corporation | 11 | $145 |
| PFIZER INC. | 1 | $117 |
| Lilly USA, LLC | 4 | $93 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Zoryve, RINVOQ, SKYRIZI, Bimzelx, CIBINQO.
Industry payments across FL — which companies pay providers there.
